Log in to save to my catalogue

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relations...

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relations...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_11f982a9e28a4e778ffdc709e74f3867

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis

About this item

Full title

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis

Publisher

England: BioMed Central Ltd

Journal title

Arthritis research & therapy, 2017-05, Vol.19 (1), p.113-113, Article 113

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Lipid profiles appear to be altered in rheumatoid arthritis (RA) patients because of disease activity and inflammation. Cholesterol efflux capacity (CEC), which is the ability of high-density lipoprotein cholesterol to accept cholesterol from macrophages, has been linked not only to cardiovascular events in the general population but also to being...

Alternative Titles

Full title

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_11f982a9e28a4e778ffdc709e74f3867

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_11f982a9e28a4e778ffdc709e74f3867

Other Identifiers

ISSN

1478-6362,1478-6354

E-ISSN

1478-6362

DOI

10.1186/s13075-017-1311-3

How to access this item